We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » International Companies Compete for Inclusion In the Global DES Market
International Companies Compete for Inclusion In the Global DES Market
June 3, 2005
Along with U.S. companies such as Medtronic and Abbott, international companies are also vying for a piece of the drug-eluting stent (DES) market currently dominated by Boston Scientific and Johnson & Johnson as evidenced by the presentations at the Paris Course on Revascularization (EuroPCR) meeting.